Empowering confident healthcare decisions through trusted laboratory service & diagnostic excellence. BioReference® Health LLC, an OPKO Health, Inc.
Company (NASDAQ: OPK), empowers confident healthcare decisions by prioritizing service, creating innovative solutions, and offering scientific expertise in oncology, urology, and women’s health. Headquartered in Elmwood Park, New Jersey, BioReference operates 10 laboratory facilities around the country, is in-network with the largest health plans in the United States and processes more than 12 million tests, annually. BioReference provides credible and tailored solutions for a variety of customers and patients, including medical practices small and large, hospitals and health systems, correctional institutions, government agencies, educational systems, and sport leagues. In addition to an extensive test menu with 99 percent of tests performed in-house, BioReference’s differentiated offerings include large-scale health screening programs, on-demand mobile phlebotomy, and transformative business solutions that optimize laboratory management. For more information visit https://www.bioreference.com/
10/31/2024
We are thrilled that Ellen Beausang, Chief Commercial Officer at BioReference/GenPath, will be one of the featured speakers at the pre-conference workshop at Pathology Visions '24 on November 3, 2024. Ellen will speak about how we successfully integrated artificial intelligence into our remote pathology offering, Stormpath, and how this helps our clients report professional interpretations of esoteric testing more quickly and accurately.
Lung Cancer represents more than one eighth of all new cancer cases in the US and is the leading cause of cancer deaths worldwide. As we wrap up National Lung Cancer Awareness Month, get informed of the facts, signs, and symptoms - and take time to speak with your healthcare provider about your risk level and if a screening might be appropriate for you. https://bit.ly/47Tv7DE
11/14/2023
'Grow it Out' in honor of men’s health throughout No Shave November. Take time this month to talk to your healthcare provider about early detection screenings for , like the 4Kscore Test from OPKO, BioReference and GenPath Oncology More on the blog ➡️ https://bit.ly/3QYaxwo
11/07/2023
BioReference® today announced we will implement SOPHiA GENETICS technology and add MSK-ACCESS® liquid biopsy to our test suite. With the implementation of SOPHiA GENETICS, BioReference will be the first laboratory globally to adopt MSK-ACCESS® powered with SOPHiA DDM™. Click to read the full release ➡️ https://bit.ly/3SyP7qP
09/26/2023
The Foundation for Women’s Cancer states that every five minutes, a woman will be diagnosed with one of the five main gynecological cancers. During the month of September, join us in acknowledging Gynecologic Cancer Awareness Month, and helping raise awareness of the various cancers, their prevalence, symptoms, diagnosis and prevention. ➡️ https://www.bioreference.com/combating-gynecologic-cancers-in-september/
09/21/2023
Screening and diagnostic tests performed by clinical laboratories inform some of life’s most important health care decisions. Join the American Clinical Laboratory Association to learn how you can help protect patient access to care by enacting , and tell Congress to : https://bit.ly/3Sg5Xr5
09/15/2023
Please join us in congratulating Susan Aveta, VP Phlebotomy, for being recognized as an honoree of this year’s “Best 50 Women in Business” by NJBIZ ➡️ https://bit.ly/3sWRBVi
09/14/2023
Today we kicked-off day one of the American Pathology Foundation National Meeting to promote the practice management and leadership of pathology through training and education. If you are in attendance, please join various exciting sessions this week hosted by BioReference colleagues Tamera Paczos, MD; Jane Pine Wood, JD; and Robin Miller Zweifel, MT (ASCP). View the conference agenda here ➡️
The American Pathology Foundation (APF) is a non-profit professional society devoted to the business and management of pathology. Founded in 1959 by pathologist leaders and laboratory industry executives, APF strives to provide high quality educational programs and practice management resources.
06/22/2023
This June, we've been honoring Men’s Health Month – a time that aims to encourage men to take charge of their overall health by implementing healthy living decisions. Many diseases that disproportionately impact men, like heart disease, diabetes, prostate cancer and more, are preventable through regular doctor’s visits and healthy lifestyle choices. Take time this month to talk with your healthcare provider and loved ones about early detection and treatment. Read more about screening and test solutions here: https://bit.ly/3q4haOE
06/14/2023
Routine tests play a critical role in healthcare, informing 70% of medical decisions (according to the CDC). Without congressional action, about 800 tests will face payment cuts, threatening access to care. Take action with the American Clinical Laboratory Association and tell Congress to pass , by signing the petition here: https://bit.ly/3Sg5Xr5
06/14/2023
screening and diagnostic tests performed by clinical laboratories inform some of life’s most important health care decisions. Join American Clinical Laboratory Association to learn how you can help protect patient access to care by enacting , and tell Congress to : https://bit.ly/3Sg5Xr5
06/05/2023
Come see us today until 5pm at (booth 2104) and learn about the suite of products with industry-leading turnaround times that GenPath Oncologyoffers healthcare providers and patients for oncological laboratory testing - including OnkoSight Advanced and OnkoClone. https://bit.ly/3bBdcoI
Be the first to know and let us send you an email when BioReference Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
BioReference has a reputation for doing things differently, and our vision is more expansive than just solving today’s problems. Our foresight and ingenuity have moved us from a concept to a billion-dollar laboratory practice, setting us on a course to advance modern medicine. While unparalleled diagnostics remain at our core, our ultimate goal is to help physicians provide better service and to empower patients with the knowledge to better care for themselves.
Our full-service offering goes beyond the lab; our people and expertise are impacting every area of medicine. GenPath Oncology maintains a strategic advantage in relation to other diagnostic laboratories that revolves around three key areas: clinical expertise, scientific innovation and cost effectiveness. GenPath Women’s Health was founded because we understand women’s health needs and know that with the right screening, testing and research we can save lives. GeneDx is at the forefront of genetic screening and analysis because nothing can be more precise than a diagnosis based on an individual’s DNA. Laboratorio Buena Salud exists because we believe you shouldn’t have to “press 2” to reach someone who speaks your own language.
Our laboratories are adapting to an evolving industry, and constantly investing in the resources, people and technology that will benefit our business, our clients and our patients in the long term. With an unwavering focus on the needs of tomorrow, we’re blazing a trail for the future of our industry – one that is built by doctors, for doctors and patients.
